Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsDoxorubicinChemotherapy, AdjuvantCombined Modality TherapyCyclophosphamideCisplatinDisease-Free SurvivalTreatment OutcomeOsteosarcomaPrognosisVincristinePrecursor Cell Lymphoblastic Leukemia-LymphomaRetrospective StudiesNeoadjuvant TherapyBreast NeoplasmsEtoposideSurvival AnalysisNeoplasm StagingLung NeoplasmsDrug Administration ScheduleMethotrexateNeoplasmsSurvival RatePaclitaxelAntibiotics, AntineoplasticAntineoplastic Agents, PhytogenicAntimetabolites, AntineoplasticAntineoplastic Agents, AlkylatingCarboplatinClinical ProtocolsVinblastineDrug Resistance, NeoplasmTaxoidsBleomycinInduction ChemotherapyNeoplasm Recurrence, LocalIfosfamideTime FactorsOrganoplatinum CompoundsDeoxycytidineCytarabineAnthracyclinesFollow-Up StudiesOvarian NeoplasmsCell Line, TumorNeoplasm MetastasisCarcinoma, Non-Small-Cell LungAdenocarcinomaDose-Response Relationship, DrugChemotherapy, Cancer, Regional PerfusionSalvage TherapyVomitingRadiotherapyLymphoma, Non-HodgkinNauseaCarmustineNeutropeniaColorectal NeoplasmsClinical Trials as TopicProspective StudiesTesticular NeoplasmsRadiotherapy, AdjuvantTransplantation, AutologousBrain NeoplasmsHodgkin DiseaseCamptothecinLomustineDaunorubicinDacarbazineApoptosisMitomycinBone NeoplasmsDrug Screening Assays, AntitumorMelphalanLiver NeoplasmsInfusions, IntravenousLeukopeniaKaplan-Meier EstimateNeoplasms, Germ Cell and EmbryonalMitoxantroneGranulocyte Colony-Stimulating FactorTumor Markers, BiologicalAntibodies, Monoclonal, HumanizedRandomized Controlled Trials as TopicRecurrenceInfusions, Intra-ArterialCarcinoma, Squamous CellPlatinum CompoundsLymphomaRadiotherapy DosageCarcinomaTumor Cells, CulturedDrug SynergismHematopoietic Stem Cell TransplantationAntiemeticsDrug TherapyLymphatic MetastasisPeritoneal NeoplasmsThiotepa